Header Logo

Connection

RAMMURTI KAMBLE to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications RAMMURTI KAMBLE has written about Imatinib Mesylate.
RAMMURTI KAMBLE
Connection Strength
0.041
Imatinib Mesylate
  1. Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant. 2020 03; 26(3):472-479.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.